KOREA PHARMA Balance Sheet Health
Financial Health criteria checks 4/6
KOREA PHARMA has a total shareholder equity of ₩70.5B and total debt of ₩28.4B, which brings its debt-to-equity ratio to 40.3%. Its total assets and total liabilities are ₩118.2B and ₩47.7B respectively. KOREA PHARMA's EBIT is ₩5.0B making its interest coverage ratio 2.6. It has cash and short-term investments of ₩44.0B.
Key information
40.3%
Debt to equity ratio
₩28.44b
Debt
| Interest coverage ratio | 2.6x |
| Cash | ₩43.97b |
| Equity | ₩70.52b |
| Total liabilities | ₩47.66b |
| Total assets | ₩118.18b |
Recent financial health updates
Is KOREA PHARMA (KOSDAQ:032300) A Risky Investment?
Nov 12
KOREA PHARMA (KOSDAQ:032300) Seems To Use Debt Quite Sensibly
Mar 26Recent updates
Is KOREA PHARMA (KOSDAQ:032300) A Risky Investment?
Nov 12Optimistic Investors Push KOREA PHARMA Co., Ltd. (KOSDAQ:032300) Shares Up 29% But Growth Is Lacking
Oct 16KOREA PHARMA (KOSDAQ:032300) Seems To Use Debt Quite Sensibly
Mar 26What You Need To Know About KOREA PHARMA Co., Ltd.'s (KOSDAQ:032300) Investor Composition
Jan 08
Financial Position Analysis
Short Term Liabilities: A032300's short term assets (₩83.0B) exceed its short term liabilities (₩26.8B).
Long Term Liabilities: A032300's short term assets (₩83.0B) exceed its long term liabilities (₩20.9B).
Debt to Equity History and Analysis
Debt Level: A032300 has more cash than its total debt.
Reducing Debt: A032300's debt to equity ratio has reduced from 73.5% to 40.3% over the past 5 years.
Debt Coverage: A032300's debt is not well covered by operating cash flow (18.2%).
Interest Coverage: A032300's interest payments on its debt are not well covered by EBIT (2.6x coverage).